Top Companies in the Latin America Autotransfusion Devices Market & Their Offerings
What are the Recent Developments in the Latin America Autotransfusion Devices Market?
- In March 2025, Stryker announced the launch of the Artix Thrombectomy System, featuring integrated blood management capabilities and compatibility with autologous blood return systems. The development reflects continued innovation in blood conservation and surgical blood recovery technologies.
- In July 2025, Stryker (through Inari Medical) introduced the next-generation InThrill Thrombectomy System, designed to improve clot removal efficiency and procedural performance. The platform supports advanced blood management approaches that align with growing demand for autologous blood recovery solutions.
Market Ecosystem Analysis
| Ecosystem Segment | Key Participants | Role in Market |
| Technology Providers | Haemonetics, Terumo, LivaNova, Medtronic, Fresenius Kabi | Develop cell salvage and autotransfusion technologies |
| Product Manufacturers | Haemonetics, Terumo, LivaNova, Braile Biomédica, EUROSETS | Manufacture autotransfusion systems and disposables |
| Service Providers | Hospital groups, surgical centers, perfusion service providers | Operate autotransfusion systems during procedures |
| Platform Providers | Haemonetics, LivaNova, Terumo | Integrated blood management platforms and perfusion ecosystems |
| CROs/CDMOs | Not a major segment in this market | Limited relevance due to device-centric nature |
| Software Vendors | Haemonetics, LivaNova | Procedure monitoring, automation, workflow management |
| Research Institutions | Major cardiovascular and surgical research hospitals across Brazil, Mexico, Argentina, and Chile | Clinical validation and PBM protocol development |
| End-User Industries | Hospitals, Cardiac Centers, Orthopedic Centers, Trauma Centers, Transplant Centers | Primary purchasers and users of autotransfusion systems |
Supply Chain Analysis
R&D
- Research and development activities in Latin America’s autotransfusion devices sector are focused on improving the efficiency, affordability, and portability of blood recovery and reinfusion systems. Manufacturers are increasingly incorporating digital and AI-enabled monitoring capabilities to enhance blood management during surgical procedures. Innovation efforts are also aimed at reducing equipment costs and addressing challenges related to limited blood supply availability in healthcare facilities.
- Key players: Braile Biomédica, Lifemed, Baumer, LivaNova, and Getinge.
Regulatory Approvals
- Clinical studies related to autotransfusion devices in Latin America focus on assessing the safety, performance, and clinical benefits of recovering and reinfusing a patient’s own blood during surgical procedures. Research evaluates blood recovery efficiency, red blood cell quality, reduction in donor blood usage, and overall patient outcomes. These studies support the adoption of advanced blood management practices across healthcare facilities.
- Key players: Braile Biomédica, Lifemed, LivaNova, Getinge, and Stryker.
Patient Support and Services
- Patient support programs associated with autotransfusion devices in Latin America emphasize effective blood management, reduced dependence on donor blood transfusions, and improved surgical safety. Healthcare providers are increasingly adopting strategies that help conserve a patient’s own blood, lower transfusion-related complications, and enhance recovery outcomes. These initiatives support better clinical efficiency and patient care across surgical settings.
- Key players: Braile Biomédica, Lifemed, Getinge, LivaNova, and Stryker.
| Tier 1 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| Haemonetics Corporation | Boston, Massachusetts | USA | Global autotransfusion leader; strongest dedicated cell salvage franchise | Cell Saver Elite+, Cell Saver 5+ |
| Terumo Corporation | Tokyo | Japan | Major cardiovascular and blood management supplier across Latin America | Advanced Perfusion Systems, Autotransfusion Solutions |
| LivaNova PLC | London | United Kingdom | Strong cardiac surgery and extracorporeal circulation portfolio | XTRA Autotransfusion System |
| Medtronic plc | Galway | Ireland | Significant cardiac surgery presence and perfusion-related technologies | Blood management and cardiac surgery solutions |
| Fresenius Kabi AG | Bad Homburg, Hesse | Germany | Strong transfusion medicine and hospital blood management footprint | Blood processing and transfusion technologies |
| Tier 2 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| EUROSETS | Medolla, Modena | Italy | Specialized perfusion and autotransfusion manufacturer | Electa Autotransfusion System |
| Braile Biomédica | São José do Rio Preto, São Paulo | Brazil | Leading Latin American cardiovascular device manufacturer | Cell salvage and perfusion products |
| B. Braun Melsungen AG | Melsungen, Hesse | Germany | Strong surgical blood management and transfusion technologies | Perfusion and blood management systems |
| Asahi Kasei Medical | Tokyo | Japan | Active in extracorporeal blood processing technologies | Blood purification and processing systems |
| Teleflex Incorporated | Wayne, Pennsylvania | USA | Surgical and critical care portfolio supporting blood management workflows | Surgical blood conservation solutions |
| Tier 3 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| Redax S.p.A. | Poggio Rusco, Mantua | Italy | Growing presence in cardiothoracic blood management | Autotransfusion and drainage systems |
| LivaNova Deutschland GmbH | Munich, Bavaria | Germany | Specialized regional cardiopulmonary solutions deployment | Autotransfusion accessories and perfusion systems |
| Sorin Group Italia | Milan, Lombardy | Italy | Legacy cardiac surgery technologies still active through installed base | Blood management systems |
| Getinge AB | Gothenburg | Sweden | Increasing focus on cardiac surgery and extracorporeal support technologies | Perfusion and cardiovascular support systems |
| Xenios AG | Heilbronn, Baden-Württemberg | Germany | Niche extracorporeal circulation specialist supporting blood management procedures | ECLS and blood circulation technologies |
Market Growth
The Latin America autotransfusion devices market size was estimated at USD 58.4 million in 2025 and is predicted to increase from USD 62.43 million in 2026 to approximately USD 113.81 million by 2035, expanding at a CAGR of 6.9% from 2026 to 2035.
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking